These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8480734)

  • 1. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Combes B; Carithers RL; Maddrey WC; Lin D; McDonald MF; Wheeler DE; Eigenbrodt EH; Muñoz SJ; Rubin R; Garcia-Tsao G
    Hepatology; 1995 Sep; 22(3):759-66. PubMed ID: 7657280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
    Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
    Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
    Invernizzi P; Setchell KD; Crosignani A; Battezzati PM; Larghi A; O'Connell NC; Podda M
    Hepatology; 1999 Feb; 29(2):320-7. PubMed ID: 9918905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid.
    Batta AK; Salen G; Abroon J
    Am J Gastroenterol; 1997 Jun; 92(6):1035-7. PubMed ID: 9177526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.
    Poupon RE; Poupon R; Balkau B
    N Engl J Med; 1994 May; 330(19):1342-7. PubMed ID: 8152446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid for chronic liver diseases.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    J Clin Gastroenterol; 1988; 10 Suppl 2():S25-31. PubMed ID: 3062082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F; Okolicsanyi L
    Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.
    Batta AK; Salen G; Arora R; Shefer S; Tint GS; Abroon J; Eskreis D; Katz S
    Hepatology; 1989 Oct; 10(4):414-9. PubMed ID: 2777202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
    Kaplan MM; Cheng S; Price LL; Bonis PA
    Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
    Stiehl A; Rudolph G; Raedsch R; Möller B; Hopf U; Lotterer E; Bircher J; Fölsch U; Klaus J; Endele R
    Hepatology; 1990 Sep; 12(3 Pt 1):492-7. PubMed ID: 2401455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bile acids in primary biliary cirrhosis.
    Bloomer JR; Allen RM; Klatskin G
    Arch Intern Med; 1976 Jan; 136(1):57-61. PubMed ID: 1247336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.